118 related articles for article (PubMed ID: 35031434)
1. The effect of lycopene supplement from different sources on prostate specific antigen (PSA): A systematic review and meta-analysis of randomized controlled trials.
Sharifi-Zahabi E; Soltani S; Malekahmadi M; Rezavand L; Clark CCT; Shidfar F
Complement Ther Med; 2022 Mar; 64():102801. PubMed ID: 35031434
[TBL] [Abstract][Full Text] [Related]
2. The effect of green tea on prostate specific antigen (PSA): A systematic review and meta-analysis of randomized controlled trials.
Sharifi-Zahabi E; Hajizadeh-Sharafabad F; Abdollahzad H; Dehnad A; Shidfar F
Complement Ther Med; 2021 Mar; 57():102659. PubMed ID: 33400976
[TBL] [Abstract][Full Text] [Related]
3. Lycopene Does Not Affect Prostate-Specific Antigen in Men with Non-Metastatic Prostate Cancer: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.
Sadeghian M; Asadi M; Rahmani S; Sadeghi N; Hosseini SA; Zare Javid A
Nutr Cancer; 2021; 73(11-12):2796-2807. PubMed ID: 33355018
[TBL] [Abstract][Full Text] [Related]
4. Lycopene for the prevention of prostate cancer.
Ilic D; Forbes KM; Hassed C
Cochrane Database Syst Rev; 2011 Nov; 2011(11):CD008007. PubMed ID: 22071840
[TBL] [Abstract][Full Text] [Related]
5. Phytotherapeutic interventions in the management of biochemically recurrent prostate cancer: a systematic review of randomised trials.
van Die MD; Bone KM; Emery J; Williams SG; Pirotta MV; Paller CJ
BJU Int; 2016 Apr; 117 Suppl 4(Suppl 4):17-34. PubMed ID: 26898239
[TBL] [Abstract][Full Text] [Related]
6. Is there a benefit from lycopene supplementation in men with prostate cancer? A systematic review.
Haseen F; Cantwell MM; O'Sullivan JM; Murray LJ
Prostate Cancer Prostatic Dis; 2009; 12(4):325-32. PubMed ID: 19901932
[TBL] [Abstract][Full Text] [Related]
7. Lycopene for the prevention and treatment of benign prostatic hyperplasia and prostate cancer: a systematic review.
Ilic D; Misso M
Maturitas; 2012 Aug; 72(4):269-76. PubMed ID: 22633187
[TBL] [Abstract][Full Text] [Related]
8. Tomato-based randomized controlled trial in prostate cancer patients: Effect on PSA.
Paur I; Lilleby W; Bøhn SK; Hulander E; Klein W; Vlatkovic L; Axcrona K; Bolstad N; Bjøro T; Laake P; Taskén KA; Svindland A; Eri LM; Brennhovd B; Carlsen MH; Fosså SD; Smeland SS; Karlsen AS; Blomhoff R
Clin Nutr; 2017 Jun; 36(3):672-679. PubMed ID: 27406859
[TBL] [Abstract][Full Text] [Related]
9. Lycopene can reduce prostate-specific antigen velocity in a phase II clinical study in Chinese population.
Zhang X; Yang Y; Wang Q
Chin Med J (Engl); 2014; 127(11):2143-6. PubMed ID: 24890168
[TBL] [Abstract][Full Text] [Related]
10. Lycopene and soy isoflavones in the treatment of prostate cancer.
Vaishampayan U; Hussain M; Banerjee M; Seren S; Sarkar FH; Fontana J; Forman JD; Cher ML; Powell I; Pontes JE; Kucuk O
Nutr Cancer; 2007; 59(1):1-7. PubMed ID: 17927495
[TBL] [Abstract][Full Text] [Related]
11. Lycopene Does Not Affect Prostate-Specific Antigen in Men with Non-Metastatic Prostate Cancer: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.
Zahabi ES; Soltani S; Shidfar F
Nutr Cancer; 2022; 74(3):806-807. PubMed ID: 35320054
[No Abstract] [Full Text] [Related]
12. Screening for prostate cancer.
Ilic D; Neuberger MM; Djulbegovic M; Dahm P
Cochrane Database Syst Rev; 2013 Jan; 2013(1):CD004720. PubMed ID: 23440794
[TBL] [Abstract][Full Text] [Related]
13. Lower prostate cancer risk in men with elevated plasma lycopene levels: results of a prospective analysis.
Gann PH; Ma J; Giovannucci E; Willett W; Sacks FM; Hennekens CH; Stampfer MJ
Cancer Res; 1999 Mar; 59(6):1225-30. PubMed ID: 10096552
[TBL] [Abstract][Full Text] [Related]
14. A randomized trial of lycopene supplementation in Tobago men with high prostate cancer risk.
Bunker CH; McDonald AC; Evans RW; de la Rosa N; Boumosleh JM; Patrick AL
Nutr Cancer; 2007; 57(2):130-7. PubMed ID: 17571945
[TBL] [Abstract][Full Text] [Related]
15. The Effect of Vitamin D Supplementation on Prostate Cancer: A Systematic Review and Meta-Analysis of Clinical Trials.
Shahvazi S; Soltani S; Ahmadi SM; de Souza RJ; Salehi-Abargouei A
Horm Metab Res; 2019 Jan; 51(1):11-21. PubMed ID: 30522147
[TBL] [Abstract][Full Text] [Related]
16. Phase I-II prospective dose-escalating trial of lycopene in patients with biochemical relapse of prostate cancer after definitive local therapy.
Clark PE; Hall MC; Borden LS; Miller AA; Hu JJ; Lee WR; Stindt D; D'Agostino R; Lovato J; Harmon M; Torti FM
Urology; 2006 Jun; 67(6):1257-61. PubMed ID: 16765186
[TBL] [Abstract][Full Text] [Related]
17. A randomized double-blind placebo controlled phase I-II study on clinical and molecular effects of dietary supplements in men with precancerous prostatic lesions. Chemoprevention or "chemopromotion"?
Gontero P; Marra G; Soria F; Oderda M; Zitella A; Baratta F; Chiorino G; Gregnanin I; Daniele L; Cattel L; Frea B; Brusa P
Prostate; 2015 Aug; 75(11):1177-86. PubMed ID: 25893930
[TBL] [Abstract][Full Text] [Related]
18. Diet and dietary supplement intervention trials for the prevention of prostate cancer recurrence: a review of the randomized controlled trial evidence.
Van Patten CL; de Boer JG; Tomlinson Guns ES
J Urol; 2008 Dec; 180(6):2314-21; discussion 2721-2. PubMed ID: 18930254
[TBL] [Abstract][Full Text] [Related]
19. Low prostate concentration of lycopene is associated with development of prostate cancer in patients with high-grade prostatic intraepithelial neoplasia.
Mariani S; Lionetto L; Cavallari M; Tubaro A; Rasio D; De Nunzio C; Hong GM; Borro M; Simmaco M
Int J Mol Sci; 2014 Jan; 15(1):1433-40. PubMed ID: 24451130
[TBL] [Abstract][Full Text] [Related]
20. Gene expression and biological pathways in tissue of men with prostate cancer in a randomized clinical trial of lycopene and fish oil supplementation.
Magbanua MJ; Roy R; Sosa EV; Weinberg V; Federman S; Mattie MD; Hughes-Fulford M; Simko J; Shinohara K; Haqq CM; Carroll PR; Chan JM
PLoS One; 2011; 6(9):e24004. PubMed ID: 21912659
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
